Polymer Capital Management US LLC Makes New Investment in Teleflex Incorporated (NYSE:TFX)

Polymer Capital Management US LLC purchased a new stake in Teleflex Incorporated (NYSE:TFX) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 1,506 shares of the medical technology company’s stock, valued at approximately $268,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. HighTower Advisors LLC increased its stake in Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after purchasing an additional 66 shares during the last quarter. Hengehold Capital Management LLC boosted its holdings in shares of Teleflex by 7.3% in the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock valued at $229,000 after buying an additional 88 shares during the period. Exchange Traded Concepts LLC grew its position in shares of Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after buying an additional 94 shares during the last quarter. Isthmus Partners LLC raised its stake in Teleflex by 7.3% during the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock worth $273,000 after acquiring an additional 105 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in Teleflex by 2.4% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company’s stock worth $888,000 after acquiring an additional 118 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Performance

TFX stock opened at $130.95 on Tuesday. The company has a market capitalization of $6.07 billion, a P/E ratio of 26.03, a PEG ratio of 1.73 and a beta of 1.19. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company has a 50-day simple moving average of $153.81 and a 200 day simple moving average of $185.45. Teleflex Incorporated has a fifty-two week low of $127.18 and a fifty-two week high of $249.91.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Sell-side analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.04%. Teleflex’s dividend payout ratio is currently 95.77%.

Analyst Ratings Changes

TFX has been the subject of several recent research reports. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Wells Fargo & Company dropped their target price on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Finally, Citizens Jmp cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, Teleflex has a consensus rating of “Hold” and an average price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.